• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类扁桃体类器官揭示了调节对ChAdOx1体液和细胞反应的固有途径。

Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1.

作者信息

Pudjohartono Maria Fransiska, Powell Kate, Barnes Eleanor, Klenerman Paul, Provine Nicholas M

机构信息

Translational Gastroenterology and Liver Unit, University of Oxford, Oxford, United Kingdom.

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

出版信息

PLoS Pathog. 2025 Aug 22;21(8):e1013432. doi: 10.1371/journal.ppat.1013432. eCollection 2025 Aug.

DOI:10.1371/journal.ppat.1013432
PMID:40845053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393735/
Abstract

The COVID-19 pandemic response demonstrated the effectiveness of adenovirus vector vaccines in inducing protective cellular and antibody responses. However, we still lack mechanistic understanding of the factors regulating immunity induced by this platform, especially innate pathways. We utilized a human tonsil organoid model to study the regulation of adaptive responses to ChAdOx1 nCoV-19. Innate activation and cytokine release occurred within 24 hours and T and B cell activation and antigen-specific antibody secretion occurred during the ensuing 14-day culture. Among the immune cell populations, plasmacytoid dendritic cells (pDCs) exhibited the highest ChAdOx1 transduction levels. pDC-derived IFN-ɑ was critical for humoral responses, but production of antigen in pDCs was dispensable. Furthermore, IL-6 enhanced humoral responses in both IFN-ɑ-dependent and independent manners, indicating intricate signaling interplay. IFN-ɑ and IL-6 also regulated the function of vaccine-activated CD4+ T cells, including TFH. These data provide key insights into innate pathways regulating ChAdOx1-induced immunity and highlights the promise of this model for vaccine platform mechanistic studies.

摘要

新冠疫情应对措施证明了腺病毒载体疫苗在诱导保护性细胞和抗体反应方面的有效性。然而,我们仍缺乏对调节该平台诱导免疫的因素的机制理解,尤其是先天免疫途径。我们利用人扁桃体类器官模型来研究对ChAdOx1 nCoV-19适应性反应的调节。先天免疫激活和细胞因子释放在24小时内发生,T细胞和B细胞激活以及抗原特异性抗体分泌在随后的14天培养过程中发生。在免疫细胞群体中,浆细胞样树突状细胞(pDC)表现出最高的ChAdOx1转导水平。pDC衍生的IFN-α对体液反应至关重要,但pDC中抗原的产生并非必需。此外,IL-6以依赖IFN-α和不依赖IFN-α的方式增强体液反应,表明存在复杂的信号相互作用。IFN-α和IL-6还调节疫苗激活的CD4+ T细胞的功能,包括滤泡辅助性T细胞(TFH)。这些数据为调节ChAdOx1诱导免疫的先天免疫途径提供了关键见解,并突出了该模型在疫苗平台机制研究方面的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/12ae02f4220c/ppat.1013432.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/da64b17e6106/ppat.1013432.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/68d4d162154c/ppat.1013432.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/83d8c15399a5/ppat.1013432.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/e5e714659439/ppat.1013432.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/32eaa3452369/ppat.1013432.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/5c910358bc66/ppat.1013432.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/7d27843349c3/ppat.1013432.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/12ae02f4220c/ppat.1013432.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/da64b17e6106/ppat.1013432.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/68d4d162154c/ppat.1013432.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/83d8c15399a5/ppat.1013432.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/e5e714659439/ppat.1013432.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/32eaa3452369/ppat.1013432.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/5c910358bc66/ppat.1013432.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/7d27843349c3/ppat.1013432.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3621/12393735/12ae02f4220c/ppat.1013432.g008.jpg

相似文献

1
Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1.人类扁桃体类器官揭示了调节对ChAdOx1体液和细胞反应的固有途径。
PLoS Pathog. 2025 Aug 22;21(8):e1013432. doi: 10.1371/journal.ppat.1013432. eCollection 2025 Aug.
2
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation.mRNA加强疫苗接种后对SARS-CoV-2产生有效的细胞免疫和中和免疫与浆细胞样树突状细胞(pDC)和B细胞活化有关。
Front Immunol. 2025 May 12;16:1580448. doi: 10.3389/fimmu.2025.1580448. eCollection 2025.
3
The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination.新冠疫苗接种后,加强针剂量对泰国医护人员特定B淋巴细胞和T淋巴细胞动态变化的影响
Sci Rep. 2025 Jul 16;15(1):25713. doi: 10.1038/s41598-025-10400-8.
4
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).人类季节性冠状病毒免疫的年龄差异以及ChAdOx1 nCoV-19(AZD1222)的免疫原性。
EBioMedicine. 2025 Jul 16;118:105847. doi: 10.1016/j.ebiom.2025.105847.
5
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学:一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
6
Distinct features of humoral and cellular immunity against Omicron breakthrough infection among chronic liver disease patients: An experience from a follow-up cohort.慢性肝病患者中针对奥密克戎突破性感染的体液免疫和细胞免疫的独特特征:一项随访队列研究经验
Hum Vaccin Immunother. 2025 Dec;21(1):2544466. doi: 10.1080/21645515.2025.2544466. Epub 2025 Aug 15.
7
Innate immunity and training to subvert original antigenic sin by the humoral immune response.固有免疫以及通过体液免疫反应颠覆原始抗原原罪的训练。
Elife. 2025 Aug 28;14:e106654. doi: 10.7554/eLife.106654.
8
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.
9
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection.两种 COVID-19 基础疫苗系列免疫原性的持续差异,由加强 mRNA 疫苗接种和突破性感染调节。
Vaccine. 2024 Jul 25;42(19):3953-3960. doi: 10.1016/j.vaccine.2024.05.003. Epub 2024 May 9.
10
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections.免疫缺陷成人在三剂基础免疫系列接种后长达6个月对新冠疫苗的体液免疫和细胞介导免疫反应及其突破性感染情况
Front Immunol. 2025 Jan 21;15:1501908. doi: 10.3389/fimmu.2024.1501908. eCollection 2024.

本文引用的文献

1
Distinct Requirements for CD4 T Cell Help for Immune Responses Induced by mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.mRNA和腺病毒载体SARS-CoV-2疫苗诱导的免疫反应对CD4 T细胞辅助的不同要求。
Eur J Immunol. 2025 Jan;55(1):e202451142. doi: 10.1002/eji.202451142. Epub 2024 Nov 27.
2
Tissue-specific sex differences in pediatric and adult immune cell composition and function.组织特异性性别差异对儿科和成人免疫细胞组成和功能的影响。
Front Immunol. 2024 May 15;15:1373537. doi: 10.3389/fimmu.2024.1373537. eCollection 2024.
3
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
类风湿关节炎患者接种第三剂严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗后免疫调节剂与突破性新型冠状病毒肺炎(COVID-19)风险:一项队列研究
Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162.
4
Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids.流感疫苗剂型在人类免疫类器官中介导不同的细胞和抗体反应。
Immunity. 2023 Aug 8;56(8):1910-1926.e7. doi: 10.1016/j.immuni.2023.06.019. Epub 2023 Jul 20.
5
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs.COVID-19 腺病毒载体疫苗在人 PBMCs、巨噬细胞和 moDCs 中诱导的干扰素和促炎反应高于 mRNA 疫苗。
Vaccine. 2023 Jun 13;41(26):3813-3823. doi: 10.1016/j.vaccine.2023.04.049. Epub 2023 Apr 25.
6
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines.一项系统免疫研究比较了成年人对 COVID-19 mRNA 疫苗和腺病毒载体疫苗的先天和适应性免疫反应。
Cell Rep Med. 2023 Mar 21;4(3):100971. doi: 10.1016/j.xcrm.2023.100971. Epub 2023 Feb 17.
7
The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination.在接受生物改善病情抗风湿药物(bDMARD)和靶向合成改善病情抗风湿药物(tsDMARD)治疗的患者中,接种SARS-CoV-2 mRNA疫苗后免疫加速衰退且加强针效果降低。
Front Med (Lausanne). 2023 Feb 9;10:1049157. doi: 10.3389/fmed.2023.1049157. eCollection 2023.
8
A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2.TLR7 纳米颗粒佐剂促进针对流感和 SARS-CoV-2 异源株的广泛免疫应答。
Nat Mater. 2023 Mar;22(3):380-390. doi: 10.1038/s41563-022-01464-2. Epub 2023 Jan 30.
9
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.Tfh 细胞和生发中心是 ChAdOx1 nCoV-19 疫苗接种后记忆 B 细胞形成和体液免疫所必需的。
Cell Rep Med. 2022 Dec 20;3(12):100845. doi: 10.1016/j.xcrm.2022.100845. Epub 2022 Nov 15.
10
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity.腺病毒载体疫苗和 mRNA 疫苗:调节其免疫原性的机制。
Eur J Immunol. 2023 Jun;53(6):e2250022. doi: 10.1002/eji.202250022. Epub 2022 Nov 20.